Guidance

National protocol for Comirnaty® 30microgram/dose COVID-19 mRNA vaccine

This protocol is for the administration of Comirnaty® 30microgram/dose COVID-19 mRNA vaccine to individuals in accordance with the national COVID-19 vaccination programme.

From:
UK Health Security Agency
Published
13 August 2021
Last updated
1 April 2022 — See all updates

This publication was withdrawn on

This protocol has been superseded by the COVID-19 adult and children 5 to 17 years national protocols.

Applies to England

Documents

[Withdrawn] National protocol for Comirnaty® 30microgram/dose COVID-19 mRNA vaccine (v07.00)

Ref: UKHSA gateway number GOV-11810

MS Word Document, 226 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This protocol is for the administration of Comirnaty® 30microgram/dose COVID-19 mRNA vaccine by appropriately trained persons.

National protocol for Comirnaty® 30microgram/dose COVID-19 mRNA vaccine v07.00 is valid from 31 March 2022 to 1 April 2023.

Updates to this page

Published 13 August 2021
Last updated 1 April 2022 + show all updates

  1. Removed expired protocol (v06.00).

  2. Added version 07.00 – see page 5 for change history.

  3. Added version 06.00 – details of changes on page 4.

  4. Added version 05.00 – details of changes on page 3.

  5. Updated JCVI link on page 11.

  6. Added version 04.00 – details of changes on page 4.

  7. Added version 03.00 – details of changes on page 3.

  8. Added version 02.00 - (details of changes on page 2).

  9. First published.

Sign up for emails or print this page